Celalettin Ustun

41PUBLICATIONS
189CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMedical infection agents (incl. prions)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jul 30, 2026
Regional practice differences significantly affect the benefit of post-HCT gilteritinib in FLT3-ITD AML.

|Jun 12, 2026
Exploring the Origin of Cells in the Progression of Primary Myelofibrosis to Acute Myeloid Leukemia Case Report.

|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib, Andreas Reiter, Deepti H Radia

|Sep 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study.

Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson

|Jul 01, 2025
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia.

Mark J Levis, Mehdi Hamadani, Brent R Logan

|Jan 24, 2025
Systemic mastocytosis: current status and challenges in 2024.

Celalettin Ustun, Fatma Keklik Karadag, Michael A Linden

Pageof 7

Frequent Collaborators

11 joint publications

Mark R Litzow

6 joint publications

Mehdi Hamadani

6 joint publications

Taiga Nishihori

5 joint publications

Mark J Levis